Citrulline / L-Citrulline for Erectile Dysfunction

Verdict: Weak, preliminary evidence; not proven for ED

Citrulline shows a faint early signal for mild erectile dysfunction, but the evidence is too thin and low-quality to recommend it as a treatment. It is not a substitute for proven options, and combining it with prescription ED drugs may be dangerous.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

The grade is Weak (Tier C) because the entire human case rests on three small, low-quality RCTs. The only trial of citrulline alone (Cormio 2011, PMID 21195829) enrolled just 24 men, ran four weeks, and was open-label rather than double-blind, so a placebo effect cannot be ruled out despite its eye-catching result (50% of men improved from mild ED to normal vs 8.3% on placebo).

The two later randomized trials (PMID 30150102 and PMID 33151048) were double-blind but tested citrulline inside multi-ingredient formulas (with resveratrol, and additionally Testofen and caffeine), so any benefit cannot be attributed to citrulline itself. One even found no significant change in erection hardness (p=0.79). No meta-analysis or systematic review exists, and doses were far below the levels typically studied.

Authorities reinforce the caution. The EU's EFSA twice issued unfavourable opinions on citrulline health claims, the US FDA treats it only as a dietary supplement with no approved claim, and the UK NHS and WHO do not address it. Mayo Clinic notes ED supplements are far less studied than prescription medicines and advises consulting a clinician first. Importantly, taking citrulline with PDE5 inhibitors (e.g. Viagra, Cialis) carries a risk of dangerously low blood pressure.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.52
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
67%
Broadly consistent
Evidence level
E6
Multiple smaller RCTs (n<500)

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.47
L1 ExamineGlobal benchmark
0.50
L3 MechanismPlausibility
0.50
L11 AI re-checkIndependent read
0.50
L2 PubMedPrimary literature
0.60
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.524
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction
PMID: 21195829 2011 RCT (open-label) n = 24
Finding: 50% (12/24) improved from mild ED to normal function vs 8.3% on placebo (p < 0.01); mean monthly intercourse increased from 1.37 to 2.3 (p < 0.01).
🟠 Limited quality Effect size: NNT ~2.4; response rate difference 41.7 percentage points
View on PubMed
Oral L-citrulline and Transresveratrol Supplementation Improves Erectile Function in Men With Phosphodiesterase 5 Inhibitors: A Randomized, Double-Blind, Placebo-Controlled Crossover Pilot Study
PMID: 30150102 2018 RCT (double-blind) n = 13
Finding: SHIM score improved significantly with active treatment (10.96 ± 1.21) vs placebo (8.31 ± 1.23), p < 0.05; EHS improvement not statistically significant (p = 0.79). Confounded by combination product.
🟠 Limited quality Effect size: SHIM MD ~2.65 points
View on PubMed
Oral Testofen, L-Citrulline, Resveratrol, and Caffeine Supplement Drink Improves Sexual Function in Men with Phosphodiesterase 5 Inhibitors: Randomized, Double-Blind, Placebo-Controlled Crossover P…
PMID: 33151048 2021 RCT (double-blind) n = 20
Finding: Multiple IIEF domains significantly improved with supplement drink vs placebo; cannot isolate citrulline contribution from multi-ingredient formula.
🟠 Limited quality Effect size: null
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Neutral
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
相關作用機轉仍在科學研究階段(the related mechanism of action remains in the scientific research stage);目前西瓜的壯陽效果尚不確定(watermelon's purported enhancement effects remain unconfirmed)。台灣食品法規好像沒有把這個成分列為可添加用途。 source↗
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
Erectile dysfunction supplements and other natural remedies have long been used in various cultures. But they haven't been studied or tested nearly as much as prescription medicines for ED. Talk with your healthcare professional before you try a supplement for erectile dysfunction. source↗
L5c Cleveland Clinic
Neutral
L5e Specialty Society (condition-mapped)
Not addressed
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-erectile-dysfunction-INT-citrulline-001 繁體中文版 →